Market IntelliX Research indicates the global market for Personalized mRNA Cancer Vaccine Therapy will achieve significant expansion, projecting growth from US$ 1440 million in 2025 to an estimated US$ 2015 million by 2031. This performance translates to a strong Compound Annual Growth Rate (CAGR) of 6.1% throughout the forecast period of 2025–2031.

Market IntelliX Research indicates the global market for Personalized mRNA Cancer Vaccine Therapy will achieve significant expansion, projecting growth from US$ 1440 million in 2025 to an estimated US$ 2015 million by 2031. This performance translates to a strong Compound Annual Growth Rate (CAGR) of 6.1% throughout the forecast period of 2025–2031.